feed,title,long_url,short_url
SeekingAlpha,Ultra microcap Synaptogenix down 5% following Biogen's Alzheimer's drug approval,https://seekingalpha.com/news/3703798,
SeekingAlpha,JPMorgan Asset Management launches growth investment platform,https://seekingalpha.com/news/3703792,
SeekingAlpha,"Biogen’s Alzheimer’s drug wins FDA approval, see which ETFs are in play",https://seekingalpha.com/news/3703806,
SeekingAlpha,Consider DGRO For Steadily Growing Income,https://seekingalpha.com/article/4433485,
